Metotreksat Ebewe

Methotrexate Disodium, the active ingredient in Metotreksat Ebewe, is an antimetabolite (folate antagonist) presented as an injectable solution for intramuscular, intravenous, and subcutaneous use. It is employed to treat rheumatoid arthritis, severe psoriasis, certain leukemias and lymphomas, and ectopic pregnancy in adult patients.

GNH USA supplies Metotreksat Ebewe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution across multiple continents.

Methotrexate Disodium is used in several disease categories where inhibition of folate metabolism is therapeutic.

- Rheumatoid arthritis: reduces joint inflammation and slows structural damage. - Psoriasis: improves severe skin lesions and plaque formation. - Acute lymphoblastic leukemia: contributes to remission by blocking malignant cell proliferation. - Non‑Hodgkin lymphoma: used in combination regimens to achieve tumor control. - Ectopic pregnancy: provides medical management to terminate trophoblastic tissue.

Methotrexate Disodium may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea and vomiting - Oral mucosal ulceration - Fatigue - Alopecia - Elevated liver enzymes - Mild skin rash

Serious or Rare Side Effects: - Bone marrow suppression leading to pancytopenia - Severe infections due to immunosuppression - Pulmonary toxicity (interstitial pneumonitis) - Hepatotoxicity with fibrosis or cirrhosis - Renal impairment or failure - Life‑threatening cutaneous reactions such as Stevens‑Johnson syndrome

Before initiating Metotreksat Ebewe, several safety considerations should be evaluated.

- Monitor blood counts: perform regular CBC to detect marrow suppression. - Assess liver function: schedule periodic LFTs for hepatotoxicity. - Evaluate renal function: adjust dosing if creatinine clearance is reduced. - Avoid in pregnancy: drug is teratogenic and contraindicated for pregnant patients. - Use effective contraception: both patients and partners should employ reliable methods during treatment and for several months after cessation. - Store at ambient temperature: keep in original container, protect from moisture and light.

Methotrexate Disodium has notable drug interactions that may require avoidance or close monitoring.

Major Interactions (Avoid): - Nonsteroidal anti‑inflammatory drugs (NSAIDs): increase methotrexate toxicity. - Proton pump inhibitors: may reduce renal clearance and raise serum levels. - Live vaccines: heightened risk of infection due to immunosuppression. - Trimethoprim‑sulfamethoxazole: additive bone‑marrow suppression. - High‑dose folic acid supplementation: can diminish therapeutic efficacy.

Moderate Interactions (Monitor Closely): - Azathioprine: combined immunosuppression may intensify infection risk. - Cyclosporine: increased nephrotoxicity when used together. - Penicillins (e.g., ampicillin): may elevate methotrexate concentrations. - Alcohol consumption: potentiates hepatotoxic effects. - Antacids containing aluminum or magnesium: reduce oral absorption of methotrexate.